Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02503423
Title Phase 1-2 Study of ASTX660 in Subjects With Advanced Solid Tumors and Lymphomas
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Astex Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | HUN | GBR | FRA | ESP | CAN | BEL


No variant requirements are available.